Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 15
Number of items: 15
  • Open Access
    Maijer, K. I. (2017). Rheumatoid arthritis: From the at risk phases all the way up to the development of the disease. [Thesis, fully internal, Universiteit van Amsterdam].
  • Doorenspleet, M. E., Klarenbeek, P. L., de Hair, M. J. H., van Schaik, B. D. C., Esveldt, R. E. E., van Kampen, A. H. C., Gerlag, D. M., Musters, A., Baas, F., Tak, P. P., & de Vries, N. (2014). Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity. Annals of the Rheumatic Diseases, 73(4), 756-762. https://doi.org/10.1136/annrheumdis-2012-202861
  • Klarenbeek, P. L., de Hair, M. J. H., Doorenspleet, M. E., van Schaik, B. D. C., Esveldt, R. E. E., van de Sande, M. G. H., Cantaert, T., Gerlag, D. M., Baeten, D., van Kampen, A. H. C., Baas, F., Tak, P. P., & de Vries, N. (2012). Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Annals of the Rheumatic Diseases, 71(6), 1088-1093. https://doi.org/10.1136/annrheumdis-2011-200612
  • Open Access
    Herenius, M. M. J., Thurlings, R. M., Wijbrandts, C. A., Bennink, R. J., Dohmen, S. E., Voermans, C., Wouters, D., Izmailova, E. S., Gerlag, D. M., van Eck-Smit, B. L. F., & Tak, P. P. (2011). Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab. Annals of the Rheumatic Diseases, 70(6), 1160-1162. https://doi.org/10.1136/ard.2010.141549
  • Open Access
    Pontifex, E. K., Gerlag, D. M., Gogarty, M., Vinkenoog, M., Gibbs, A., Burgman, I., Fearon, U., Bresnihan, B., Tak, P. P., Gibney, R. G., Veale, D. J., & FitzGerald, O. (2011). Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study. Arthritis Research & Therapy, 13(1), R7. https://doi.org/10.1186/ar3228
  • Open Access
    van Kuijk, A. W. R., Vergunst, C. E., Gerlag, D. M., Bresnihan, B., Gomez-Reino, J. J., Regine, R., Verschueren, P. C., van der Leij, C., Maas, M., Kraan, M. C., & Tak, P. P. (2010). CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial. Annals of the Rheumatic Diseases, 69(11), 2013-2016. https://doi.org/10.1136/ard.2010.131235
  • Open Access
    Thurlings, R. M., Teng, O., Vos, K., Gerlag, D. M., Aarden, L., Stapel, S. O., van Laar, J. M., Tak, P. P., & Wolbink, G. J. (2010). Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 69(2), 409-412. https://doi.org/10.1136/ard.2009.109041
  • Open Access
    van Kuijk, A. W. R., DeGroot, J., Koeman, R. C., Sakkee, N., Baeten, D. L., Gerlag, D. M., & Tak, P. P. (2010). Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo. PLoS ONE, 5(9), Article e12556. https://doi.org/10.1371/journal.pone.0012556
  • Open Access
    Wijbrandts, C. A., van Leuven, S. I., Boom, H. D., Gerlag, D. M., Stroes, E. G. S., Kastelein, J. J. P., & Tak, P. P. (2009). Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. Annals of the Rheumatic Diseases, 68(8), 1316-1321. https://doi.org/10.1136/ard.2007.086728
  • Open Access
    Wijbrandts, C. A., Klaasen, R., Dijkgraaf, M. G. W., Gerlag, D. M., van Eck-Smit, B. L., & Tak, P. P. (2009). Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Annals of the Rheumatic Diseases, 68(3), 373-376. https://doi.org/10.1136/ard.2008.091611
Page 1 of 2